Duke University's nationally-leading HIV vaccine research consortium, operating since 2005 with several vaccine candidates approaching clinical trial phase, is losing major NIH funding support. The funding discontinuation represents a substantial setback for domestic HIV therapeutic development efforts.
Original (en)
Duke has led a national HIV research consortium since 2005, with several promising vaccines ready for trials. Now the NIH is ending its major grant.
Counterfeit Keytruda (pembrolizumab), an immunotherapy cancer treatment, has infiltrated pharmaceutical supply chains and reached patients and hospitals. The fake medications pose potentially fatal consequences for cancer patients depending on authentic treatment, indicating significant health system vulnerability to pharmaceutical fraud.
The World Food Programme reports a significant funding shortfall that could result in cuts to humanitarian aid in Sudan within weeks as famine conditions worsen. More families across Sudan are being pushed toward famine as international support mechanisms face resource constraints.
UNICEF warns that children in Darfur are facing a new humanitarian catastrophe, two decades after the initial crisis. The alert highlights ongoing vulnerability of the child population and suggests critical gaps in humanitarian response in the region.
d1deed1a…openwatch.io →